Overview

Safety and Tolerability of Single and Multiple Doses of VAK694 in Healthy and Atopic Subjects

Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and tolerability of single and multiple doses of VAK694 in healthy volunteers and otherwise healthy volunteers with a history of allergies.
Phase:
Phase 1
Details
Lead Sponsor:
Novartis